Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor―Positive, Human Epidermal Growth Factor Receptor 2―Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

Thomas Bachelot; Céline Bourgier; Eric Legouffe; Djelila Allouache; Claude EL KOURI; Eric PUJADE-LAURAINE; Claire Cropet; Isabelle RAY-COQUARD; Jean-Marc Ferrero; Gilles Freyer; Sophie ABADIE-LACOURTOISIE; Jean-Christophe Eymard; Marc Debled; Dominique Spaëth

doi:10.1200/JCO.2011.39.0708

Retour

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor―Positive, Human Epidermal Growth Factor Receptor 2―Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

Article de revue

Avec comité de lecture

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor―Positive, Human Epidermal Growth Factor Receptor 2―Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

Thomas Bachelot, Céline Bourgier, Eric Legouffe, Djelila Allouache, Claude EL KOURI, Eric PUJADE-LAURAINE, Claire Cropet, Isabelle RAY-COQUARD, Jean-Marc Ferrero, Gilles Freyer, …

Journal of clinical oncology, Vol.30(22), pp.2718-2724

01/08/2012

DOI: https://doi.org/10.1200/JCO.2011.39.0708

PMID: 22565002

Résumé

Biological and medical sciences

Gynecology. Andrology. Obstetrics

Mammary gland diseases

Medical sciences

Tumors

Indicateurs

1 Consultations de la notice

Détails

Titre: Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor―Positive, Human Epidermal Growth Factor Receptor 2―Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
Créateurs - sans rôle: Thomas Bachelot - Centre Léon Bérard
Céline Bourgier - Institut Gustave Roussy
Eric Legouffe - Eric Legouffe, Clinique de Valdegour, Nîmes, France
Djelila Allouache - Centre François Balcesse, Caen, France
Claude EL KOURI - Centre Catherine de Sienne, Nantes, France
Eric PUJADE-LAURAINE - Assistance Publique – Hôpitaux de Paris
Claire Cropet - Université Lyon 1, Centre Leon Berard, Lyon, France
Isabelle RAY-COQUARD - Centre Léon Bérard
Jean-Marc Ferrero - Centre Antoine Lacassagne, Nice, France
Gilles Freyer - Hôpital Lyon Sud
Sophie ABADIE-LACOURTOISIE - Centre Paul Papin, Angers, France
Jean-Christophe Eymard - Institut Jean Godinot, Reims, France
Marc Debled - Institut Bergonié
Dominique Spaëth - Dominique Spaeth, Centre d'Oncologie de Gentilly, Nancy, France
Détails de publication: Journal of clinical oncology, Vol.30(22), pp.2718-2724
Éditeur: American Society of Clinical Oncology
Nombre de pages: 7
Identifiants: 99162933209311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article